BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9022745)

  • 1. Automated rescreening in cervical cytology. Mathematical models for evaluating overall process sensitivity, specificity and cost.
    Kaminsky FC; Benneyan JC; Mullins DL
    Acta Cytol; 1997; 41(1):209-23. PubMed ID: 9022745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality assurance in cervical cytology screening. Comparison of rapid rescreening and the PAPNET Testing System.
    Halford JA; Wright RG; Ditchmen EJ
    Acta Cytol; 1997; 41(1):79-81. PubMed ID: 9022730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAPNET Testing System. Technical update.
    Denaro TJ; Herriman JM; Shapira O
    Acta Cytol; 1997; 41(1):65-73. PubMed ID: 9022728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neural-network-assisted analysis and microscopic rescreening in presumed negative cervical cytologic smears. A comparison.
    Mango LJ; Valente PT
    Acta Cytol; 1998; 42(1):227-32. PubMed ID: 9479345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated screening for cervical cancer: diagnostic decision procedures.
    Bartels PH; Wied GL
    Acta Cytol; 1997; 41(1):6-10. PubMed ID: 9022719
    [No Abstract]   [Full Text] [Related]  

  • 6. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears: I. A prospective intended use study.
    Patten SF; Lee JS; Wilbur DC; Bonfiglio TA; Colgan TJ; Richart RM; Cramer H; Moinuddin S
    Cancer; 1997 Dec; 81(6):337-42. PubMed ID: 9438458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulation of primary cervical cancer screening by the PAPNET system in an unscreened, high-risk community.
    Michelow PM; Hlongwane NF; Leiman G
    Acta Cytol; 1997; 41(1):88-92. PubMed ID: 9022732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consistency of a double PAPNET scan of cervical smears.
    Jenny J; Isenegger I; Boon ME; Husain OA
    Acta Cytol; 1997; 41(1):82-7. PubMed ID: 9022731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of cervical-vaginal rescreening.
    Raab SS
    Am J Clin Pathol; 1997 Nov; 108(5):525-36. PubMed ID: 9353091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State of the Art Symposium: prescreening and rescreening.
    O'Leary TJ
    Cancer; 2004 Dec; 102(6):331-3. PubMed ID: 15540232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in cervical screening technology.
    Stoler MH
    Mod Pathol; 2000 Mar; 13(3):275-84. PubMed ID: 10757338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter comparison of manual and automated screening of AutoCyte gynecologic preparations.
    Bishop JW; Kaufman RH; Taylor DA
    Acta Cytol; 1999; 43(1):34-8. PubMed ID: 9987448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stanley F. Patten, Jr., M.D., Ph.D. and the development of an automated Papanicolaou smear screening system.
    Lee JS; Nelson AC
    Cancer; 1997 Dec; 81(6):332-6. PubMed ID: 9438457
    [No Abstract]   [Full Text] [Related]  

  • 14. PAPNET for cervical cytology screening. Experience in Greece.
    Veneti S; Papaefthimiou M; Symiakaki H; Ioannidou-Mouzaka L
    Acta Cytol; 1999; 43(1):30-3. PubMed ID: 9987447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of costs and benefits of advances in cytologic technology. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Melamed MR; Hutchinson ML; Kaufman EA; Schechter CB; Garner D; Kobler TP; Krieger PA; Reith A; Schenck U
    Acta Cytol; 1998; 42(1):69-75. PubMed ID: 9479325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assisted primary screening using the automated ThinPrep Imaging System.
    Biscotti CV; Dawson AE; Dziura B; Galup L; Darragh T; Rahemtulla A; Wills-Frank L
    Am J Clin Pathol; 2005 Feb; 123(2):281-7. PubMed ID: 15842055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness and cost effectiveness of automated and semi-automated cervical screening devices: a systematic review of the literature.
    Broadstock M
    N Z Med J; 2001 Jul; 114(1135):311-3. PubMed ID: 11556445
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical validation of interactive cytologic screening. Automating the search, not the interpretation.
    Mango LJ
    Acta Cytol; 1997; 41(1):93-7. PubMed ID: 9022733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening.
    Faraker CA
    Cytopathology; 1993; 4(1):47-50. PubMed ID: 8453016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the Pathfinder in a cytology laboratory.
    Coggi G; Bulfamante G; Romeo M; Falleni M; Aldovini A; Cirillo G; Federico D; Roncalli M
    Acta Cytol; 1997; 41(1):166-72. PubMed ID: 9022740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.